Antithrombotic strategies for atrial fibrillation combined with acute coronary syndrome
LU Xiao-feng
CHEN Song-wen
LIU Shao-wen
Abstract：Atrial fibrillation(AF)is the most common sustained arrhythmia in clinical practice.Anticoagulation is the cornerstone treatment for preventing the thromboembolic complications of AF.Antiplatelet therapy is crucial for prevention and treatment of acute coronary syndrome(ACS),which is one of the leading causes of death globally.However,if the AF patients are with ACS,combining anticoagulntion with antiplatelet therapy(triple antithrombotic therapy)may increase the risk of bleeding.The selection of appropriate antithrombotic strategy has always been the focus of clinical practice.In this paper,we will summarize the antithrombotic strategies in managing AF combined with ACS based on clinical trials,guidelines,and expert consensus.
Keywords：atrial fibrillationacute coronary syndromeantithrombotic therapy
Publication Date：2024-02-01
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)
Pages：5( 104-108 )